Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: Clinical follow-up and improved new vectors

Human Gene Therapy

Volumn 9, Issue 15, 1998, Pages 2243-2251

  Verzeletti, Simona ^a   Bonini, Chiara ^a   Marktel, Sarah ^a   Nobili, Nadia ^a   Ciceri, Fabio ^a   Traversari, Catia ^a   Bordignon, Claudio ^a  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; NEOMYCIN; NERVE GROWTH FACTOR RECEPTOR; THYMIDINE KINASE; VIRUS VECTOR;

ANTIGEN SPECIFICITY; ARTICLE; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RESISTANCE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; LEUKEMIA; LYMPHOCYTE; MARKER GENE; PROMOTER REGION; RETROVIRUS; SOUTHERN BLOTTING; SUICIDE GENE; T LYMPHOCYTE;

HERPES; HERPESVIRIDAE; SAIMIRI; SAIMIRIINE HERPESVIRUS 2; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0032505705     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.15-2243     Document Type: Article

References (9)

1. BONINI, C., FERRARI, G., VERZELETTI, S., SERVIDA, P., ZAPPONE, E., RUGGIERI, L. PONZONI, M., ROSSINI, S., MAVILIO, F., TRAVERSARI, C., and BORDIGNON, C. (1997). HSVTK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
2. BORDIGNON, C., and BONINI, C. (1995). A clinical protocol for gene transfer into peripheral blood lymphocytes for in vivo immunomod-ulation of donor antitumor immunity in patients affected by recurrent disease after allogeneic bone marrow transplantation. Hum. Gene Ther. 2, 813-819.
3. CHALLITA, P.M., and KOHN, D.B. (1994) Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. U.S.A. 91, 2567-2571.
4. COHEN, J.L., BOYER, O., SALOMON, B., ONCLECQ, R., CHARLOTTE, F., BRUEL, S., BOISSERIE, G., and KLATZMANN, D. (1997). Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes. Blood 89, 4636-4645.
5. CULVER, K.W., ANDERSON, W.F., and BLAESE, R.M. (1991). Lymphocyte gene therapy. Hum. Gene Ther. 2, 107-108.
6. GOLDMAN, J.M., GALE, R.P., HOROWTTZ, M.M., BIGGS, J.C., CHAMPLIN, R.E., GLUCKMAN, E., HOFFMANN, R.G., JACOBSEN, S.J., MARMONT, A.M., McGLAVE, P.B., MESSNER, H.A., RIMM, A.A., ROZMAN, C., SPECK, B., TURA, S., WEINER, R.S., and BORTIN, M.M. (1988). Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Ann. Intern. Med. 108, 806-814.
7. HUBER, B.E., AUSTIN, E.A., GOODS, S.S., KNICK, V.C., TIBBELS, S., and RICHARDS, C.A. (1993). In vivo anti-tumor immunity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53, 4619-4626.
8. WALTER, E.A., GREENBERG, P.D., GILBERT, M.J., FINCH, R.J., WATANABE, K.S., THOMAS, E.D., and RIDDELL, S.R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038-1044.
9. WEI, M.X., TAMIYA, T., CHASE, M., BOVIATSIS, E.J., CHANG, T.K., KOWALL, N.N., HOCHBERG, F.H., WAXMAN, D.J., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994). Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene. Hum. Gene Ther. 5, 969-978.